CN Stock MarketDetailed Quotes
000403 Pacific Shuanglin Bio-pharmacy
- 21.67
- -0.09-0.41%
Market Closed Dec 13 15:00 CST
15.84BMarket Cap19.13P/E (TTM)
22.05High21.56Low207.06KlotVolume21.73Open21.76Pre Close451.02MTurnover3.02%Turnover Ratio25.89P/E (Static)731.07MShares30.4452wk High2.03P/B14.84BFloat Cap19.4652wk Low23.94Limit Up684.71MShs Float49.97Historical High19.58Limit Down2.25%Amplitude0.66Historical Low0.35Dividend TTM21.78Avg Price96.57KlotAsk1.62%Div YieldTTM100Lot Size96.72KlotBid
Pacific Shuanglin Bio-pharmacy Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 37.49%1.89B | 60.23%1.14B | 67.00%435.64M | -3.18%2.33B | -7.95%1.37B | -28.45%709.07M | -47.87%260.86M | 21.98%2.41B | 11.27%1.49B | 25.35%991.05M |
| Operating revenue | 37.49%1.89B | 60.23%1.14B | 67.00%435.64M | -3.18%2.33B | -7.95%1.37B | -28.45%709.07M | -47.87%260.86M | 21.98%2.41B | 11.27%1.49B | 25.35%991.05M |
| Other operating revenue | ---- | -74.34%639.45K | ---- | -65.97%3.27M | ---- | 335.96%2.49M | ---- | 82.15%9.59M | ---- | 246.63%571.6K |
| Total operating cost | 23.84%1.28B | 34.90%772.12M | 36.27%297.49M | -6.49%1.64B | -6.64%1.03B | -22.60%572.35M | -43.22%218.31M | 17.88%1.75B | 11.09%1.11B | 24.83%739.46M |
| Operating cost | 36.21%935.38M | 55.70%565.85M | 57.26%211.64M | -1.87%1.13B | -8.63%686.74M | -30.32%363.42M | -50.55%134.58M | 8.29%1.15B | 6.50%751.61M | 23.14%521.57M |
| Operating tax surcharges | 32.01%15.46M | 42.75%9.47M | 61.35%4.54M | 29.15%21.69M | 10.16%11.71M | -6.43%6.63M | -27.56%2.81M | 9.93%16.8M | 2.49%10.63M | 12.40%7.09M |
| Operating expense | -6.71%188.69M | -14.89%102.99M | -18.05%33.96M | -28.53%285.57M | -7.01%202.26M | -5.81%121.01M | -40.66%41.43M | 74.28%399.57M | 41.68%217.51M | 56.60%128.47M |
| Administration expense | 7.75%131.08M | 4.70%85.13M | 2.78%39.94M | 8.93%180.25M | -0.08%121.65M | -1.63%81.31M | 6.04%38.86M | -12.78%165.48M | -11.25%121.75M | -0.74%82.65M |
| Financial expense | 13.78%-36.95M | 15.10%-24.95M | 1.42%-13.46M | -4.08%-57.57M | -10.24%-42.85M | -14.82%-29.39M | -8.11%-13.65M | -20.83%-55.31M | -13.42%-38.87M | -24.73%-25.6M |
| -Interest expense (Financial expense) | 24.02%7.68M | 22.50%5.48M | -18.25%2.01M | -19.96%9.63M | -24.14%6.2M | -21.33%4.47M | -8.83%2.46M | 11.60%12.03M | -14.43%8.17M | -31.46%5.69M |
| -Interest Income (Financial expense) | 10.67%-44.95M | 9.92%-30.7M | 4.55%-15.69M | -3.84%-67.68M | -3.00%-50.32M | -7.24%-34.08M | -6.25%-16.44M | -11.24%-65.18M | -11.43%-48.85M | -10.10%-31.78M |
| Research and development | -14.48%45.98M | 14.52%33.64M | 46.17%20.86M | 5.73%79.69M | 21.84%53.76M | 16.25%29.37M | -2.06%14.27M | 111.52%75.36M | 85.63%44.12M | 42.39%25.27M |
| Credit Impairment Loss | -64.56%2.86M | -79.15%1.87M | -88.05%1.44M | 127.17%3.21M | 291.92%8.07M | 310.76%8.97M | 2,764.23%12.06M | -25.20%-11.82M | 33.48%-4.2M | -31.64%-4.26M |
| Asset Impairment Loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 100.12%124.41K | ---- | ---- |
| Other net revenue | -9.54%28.13M | -25.16%18.44M | -46.86%10.96M | -48.51%5.96M | 170.58%31.09M | 1,334.39%24.64M | 397.92%20.62M | 148.49%11.58M | 109.73%11.49M | -62.99%1.72M |
| Fair value change income | -218.38%-10.59M | -342.28%-13.7M | -254.95%-4.24M | -484.85%-18.97M | 217.43%8.95M | 1,546.93%5.66M | 87.47%2.74M | -93.36%4.93M | --2.82M | --343.43K |
| Invest income | 574.51%29.39M | 839.73%24.37M | 1,301.96%8.65M | 143.66%7.4M | 65.46%4.36M | 62.56%2.59M | -44.95%616.69K | -17.92%3.04M | -47.87%2.63M | -41.76%1.6M |
| Asset deal income | 382.99%58.07K | 5,588.70%683.96K | 110,562.94%595.4K | -224.40%-544.96K | -97.25%12.02K | 237.07%12.02K | -85.90%538.03 | 64.53%438.08K | 890.65%437.78K | -109.78%-8.77K |
| Other revenue | -33.96%6.41M | -29.62%5.21M | -13.31%4.52M | -0.01%14.86M | -0.95%9.71M | 83.24%7.41M | 158.96%5.21M | 34.24%14.86M | 46.30%9.8M | -19.86%4.04M |
| Operating profit | 71.41%638.75M | 137.04%382.5M | 136.04%149.11M | 4.79%695.19M | -6.42%372.64M | -36.30%161.36M | -47.40%63.17M | 44.09%663.43M | 13.33%398.21M | 24.86%253.31M |
| Add:Non operating Income | -96.77%105.9K | -90.82%98.68K | 56,550.50%107.88K | 40.42%3.53M | 2,240.22%3.28M | 668.70%1.08M | 15,509.02%190.43 | 369.58%2.52M | 198.87%140.3K | 275.39%139.86K |
| Less:Non operating expense | 230.11%19.31M | 277.66%11.74M | 3,121.51%8.27M | 91.09%10.61M | 221.78%5.85M | 109.80%3.11M | -77.22%256.78K | 88.10%5.55M | 262.82%1.82M | 336.78%1.48M |
| Total profit | 67.41%619.55M | 132.76%370.85M | 124.03%140.95M | 4.20%688.11M | -6.67%370.07M | -36.77%159.33M | -47.12%62.92M | 44.19%660.39M | 12.99%396.54M | 24.38%251.97M |
| Less:Income tax cost | 73.51%76.79M | 168.72%43.88M | 184.83%19.08M | 5.41%76.64M | -3.77%44.26M | -46.25%16.33M | -48.36%6.7M | 9.37%72.7M | -1.20%45.99M | 15.89%30.38M |
| Net profit | 66.59%542.76M | 128.65%326.98M | 116.78%121.87M | 4.05%611.47M | -7.06%325.81M | -35.47%143M | -46.97%56.22M | 50.10%587.69M | 15.16%350.55M | 25.64%221.59M |
| Net profit from continuing operation | 66.59%542.76M | 128.65%326.98M | 116.78%121.87M | 4.05%611.47M | -7.06%325.81M | -35.47%143M | -46.97%56.22M | 50.10%587.69M | 15.16%350.55M | 25.64%221.59M |
| Less:Minority Profit | 106.68%25.52K | 93.69%-8.59K | 50.02%-78.85K | -214.31%-638.57K | -138.00%-382.1K | -123.26%-136.17K | -139.51%-157.77K | 17.35%558.65K | 110.10%1.01M | 43.67%585.52K |
| Net profit of parent company owners | 66.38%542.73M | 128.44%326.98M | 116.31%121.95M | 4.25%612.11M | -6.68%326.2M | -35.23%143.14M | -46.62%56.38M | 50.14%587.13M | 15.01%349.54M | 25.60%221.01M |
| Earning per share | ||||||||||
| Basic earning per share | 66.48%0.7425 | 128.50%0.4474 | 116.47%0.1669 | 4.34%0.8384 | -6.77%0.446 | -35.29%0.1958 | -46.68%0.0771 | 44.96%0.8035 | 9.90%0.4784 | 17.29%0.3026 |
| Diluted earning per share | 66.48%0.7425 | 128.50%0.4474 | 116.47%0.1669 | 4.38%0.8384 | -6.69%0.446 | -35.25%0.1958 | -46.61%0.0771 | 45.24%0.8032 | 10.09%0.478 | 17.48%0.3024 |
| Other composite income | -126.87%-5.64K | -86.47%3.46K | 111.10%1.01K | -69.03%11.04K | -72.62%20.99K | 154.34%25.57K | -254.99%-9.14K | 36,365.92%35.64K | 76.65K | 10.05K |
| Other composite income of parent company owners | -126.87%-5.64K | -86.47%3.46K | 111.10%1.01K | -69.03%11.04K | -72.62%20.99K | 154.34%25.57K | -254.99%-9.14K | 36,365.92%35.64K | --76.65K | --10.05K |
| Total composite income | 66.57%542.75M | 128.61%326.98M | 116.82%121.87M | 4.04%611.48M | -7.07%325.83M | -35.46%143.03M | -46.98%56.21M | 50.11%587.73M | 15.19%350.62M | 25.65%221.6M |
| Total composite income of parent company owners | 66.37%542.73M | 128.40%326.99M | 116.35%121.95M | 4.25%612.12M | -6.69%326.22M | -35.23%143.16M | -46.63%56.37M | 50.15%587.17M | 15.04%349.62M | 25.61%221.02M |
| Total composite income of minority owners | 106.68%25.52K | 93.69%-8.59K | 50.02%-78.85K | -214.31%-638.57K | -138.00%-382.1K | -123.26%-136.17K | -139.51%-157.77K | 17.35%558.65K | 110.10%1.01M | 43.67%585.52K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
